Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates

Toxicology

Volumn 113, Issue 1-3, 1996, Pages 31-39

  Kohn, Michael C ^a   Melnick, Ronald L ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

1,3 butadiene; parameter sensitivity; toxicokinetic modeling

Indexed keywords

1,3 BUTADIENE; CARCINOGEN; EPOXIDE HYDROLASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DETOXIFICATION; INHALATION; LIVER; LUNG; METABOLITE; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ANIMALIA;

EID: 0030605127     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(96)03424-5     Document Type: Conference Paper

References (36)

1. Altman, P.L. and Dittmer, D.S. (Eds) (1971) Respiration and Circulation. Federation of American Societies for Experimental Biology, Bethesda, MD, pp. 384-385.
2. Bolt, H.M., Filser, J.G. and Stormer, F. (1984) Inhalation pharmacokinetics based on gas uptake studies. V. Comparitive pharmacokinetics of ethylene and 1,3-butadiene in rats. Arch. Toxicol. 55, 213-218.
3. Bond, J.A., Dahl, A.R., Henderson, R.F., Dutcher, J.S., Mauderly, J.L. and Birnbaum, L.S. (1986) Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol. 84, 617-627.
4. Cervello, I., Giralt, M., Nogues, M.R., Ortin, F., Puerto, A.M. and Mallol, J. (1994) Modifications of glutathione S-transferase (GST) activity in the last period of pregnancy in rats treated with benzo[a]pyrene (BP). Placenta 15, 431-440.
5. Chen, T.S., Richie, J.P. and Lang, C.A. (1990) Life span profiles of glutathione and acetaminophen detoxification. Drug Metab. Dispos. Biol. Fate Chem. 18, 882-887.
6. Csanady, G.A., Guengerich, F.P. and Bond, J.A. (1992) Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats, and mice. Carcinogenesis 13, 1143-1153.
7. Davies, B. and Morris, T (1993) Physiological parameters in laboratory animals and humans. Pharm. Res. 10, 1093-1095.
8. Delp, M.D, Manning, R.O., Bruckner, J.V. and Armstrong, R.B. (1991) Distribution of cardiac output during diurnal changes of activity in rats. Am. J. Physiol. 261, H1487-H1493.
9. de Meester, P.F., Roberfroid, M. and Mercier, M. (1980) The mutagenicity of butadiene towards Salmonella typhimurium. Toxicol. Lett. 6, 125-130.
10. de Waziers, I., Cugnenc, P.H., Yang, C.S., Leroux, J.-P. and Beaune, P.H. (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. Pharmacol. Exp. Ther. 253, 387-394.
11. Deutschmann, S. and Laib, R.J. (1989) Concentration-dependent depletion of non-protein sulfhydryl (NPSH) content in lung, heart and liver tissue of rats and mice after cute inhalation exposure to butadiene. Toxicol. Lett. 45, 175-183.
12. Evelo, C.T.A., Ostendorp, J.G.M., ten Berge, W.F. and Borm, P.J.A. (1993) Physiologically based pharmacokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses. Environ. Health Perspect. 101, 496-502.
13. Filser, J.G. and Bolt, H.M. (1984) Inhalation pharmacokinetics based on gas uptake studies. VI. Comparitive evaluation of ethylene and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats. Arch. Toxicol. 55, 219-223.
14. Himmelstein, M.W., Turner, M.J., Asgharian, B. and Bond, J.A. (1994) Comparison of blood concentration of 1,3-butadiene and butadiene epoxides in mice an rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15, 1479-1486.
15. Huff, J.E., Melnick, R.L., Solleveld, H.A., Haseman, J.K., Powers, M. and Miller, R.A. (1985) Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 227, 548-549.
16. Johanson, G. and Filser, J.G. (1993) A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation. Arch. Toxicol. 67, 131-163.
17. Kohn, M.C. and Melnick, R.L. (1993) Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control. Carcinogenesis 14, 619-628.
18. Kohn, M.C., Hines, M.L., Kootsey, J.M. and Feezor, M.D. (1994) A block organized model builder. Math. Comput. Model. 19, 75-97.
19. Kootsey, J.M., Kohn, M.C., Feezor, M.D., Mitchell, G.R. and Fletcher, P.R. (1986) SCoP: an interactive simulation control program for micro- and minicomputers. Bull. Math. Biol. 48, 427-441.
20. Kreiling, R., Laib, R.J. and Bolt, H.M (1986) Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics. Arch. Toxicol. 58, 235-238.
21. Kreiling, R., Laib, R.J., Filser, J.G. and Bolt, H.M. (1987) Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis. Arch. Toxicol. 61, 7-11.
22. Laib, R.J., Filser, J.G., Kreiling, R., Vangala, R.R. and Bolt, H.M. (1990) Inhalation pharmaco-kinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice. Environ. Health Perspect. 86, 57-63.
23. Malvoisin, E. and Roberfroid, M. (1982) Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 12, 137-144.
24. Matanoski, G.M., Santos-Burgoa, C. and Schwartz, L. (1990) Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982). Environ. Health Perspect. 86, 107-117.
25. Medinsky, M.A., Leavens, T.L., Csanady, G.A., Gargas, M.L. and Bond, J.A. (1994) In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. Carcinogenesis 15, 1329-1340.
26. Melnick, R.L., Huff, J., Chou, B.J. and Miller R. (1990) Carcinogenicity of 1,3-butadiene in C57BL/6 × C3H F1 mice at low exposure concentrations. Cancer Res. 50, 6592-6599.
27. Owen, P.E., Glaister, J.R., Gaunt, I.F. and Pullinger, D.H. (1987) Inhalation toxicity studies with 1,3-butadiene. 3. Two-year toxicity/carcinogenicity studies in rats. Am. Ind. Hyg. Assoc. J. 48, 407-413.
28. Roth, W.L., Freeman, R.A. and Wilson, A.G.E. (1993) A physiologically based model for gastrointestinal absorption and excretion of chemicals carried by lipids. Risk Anal. 13, 531-543.
29. Sabourin, P.J., Burka, L.T., Bechtold, W.E., Dahl, A.R., Hoover, M.D., Chang, I.Y. and Henderson, R.F. (1992) Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene. Carcinogenesis 13, 1633-1638.
30. Santos-Burgoa, C., Matanoski, G.M., Zeger, S.L. and Schwartz, L. (1992) Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Am. J. Epidemiol. 136, 843-854.
31. Sharer, J.E., Duescher, R.J. and Elfarra, A.A. (1992) Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats. Possible role in 1,3-butadiene-induced toxicity. Drug Metab. Dispos. 20, 658-664.
32. Tuey, D.B. and Matthews, H.B. (1980) Distribution and excretion of 2,2′,4,4′,5,5′-hexabromobiphenyl in rats and man: pharmacokinetic model predictions. Toxicol. Appl. Pharmacol. 53, 420-431.
33. USITC (1990) Synthetic organic chemicals; United States production and sales, 1989. United States International Trade Commission, Publ. 2338, U.S. Government Printing Office, Washington, DC.
34. van Duuren, B.L., Nelson, N., Orris, L., Palmes, E.D. and Schmitt, F.L. (1963) Carcinogenicity of epoxides, lactones, and peroxy compounds. J. Natl. Cancer Inst. 31, 41-55.
35. Wade, M.J., Moyer, J.W. and Hine, C.H. (1979) Mutagenic action of a series of epoxides. Mutat. Res. 66, 367-371.
36. Yeung, J.H. (1991) The effects of bucillamine on glutathione and glutathione-related enzymes in the mouse. Biochem. Pharmacol. 42, 847-852.